Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean-Claude Givel.
European Journal of Cancer | 1993
Gabriella De Vita; Pasquale Barba; Nicolas Odartchenko; Jean-Claude Givel; Giancarlo Freschi; Giorgio Bucciarelli; Maria Cristina Magli; Edoardo Boncinelli; Clemente Cillo
Homeobox genes are a network of genes encoding nuclear proteins functioning as transcriptional regulators. Human and murine homeobox genes of the HOX family are organised in four clusters on different chromosomes. Gene order within each cluster is highly conserved, perhaps in direct relation to their expression. Homeobox genes have recently been involved in normal development and oncogenesis. We have analysed HOX gene expression in normal human colon and in primary and metastatic colorectal carcinomas. The majority of HOX genes are active in normal adult colon and their overall expression pattern is characteristic of this organ. Furthermore, the expression of some HOX genes is identical in normal and neoplastic colon indicating that these genes may exert an organ-specific function. In contrast, other HOX genes exhibit altered expression in primary colon cancers and their hepatic metastases which may suggest an association with colon cancer progression.
European Journal of Cancer | 1992
Harald Lahm; Danuta Petral-Malec; Aysim Yilmaz-Ceyhan; Jürgen Fischer; Murielle Lorenzoni; Jean-Claude Givel; Nicolas Odartchenko
We analysed the effect of interleukin-1 (IL-1), IL-6 and transforming growth factor beta 1 (TGF beta 1) on the growth of a panel of eight colorectal carcinoma cell lines. IL-1 stimulated growth of two lines (LS411N and LS1034) up to 20-fold and IL-6 enhanced proliferation of LS1034 more than 5-fold. Both cytokines also augmented colony-formation of LS1034 in methylcellulose. Under both growth conditions IL-1 was the most potent stimulator. However, the addition of IL-6 to IL-1 synergistically enhanced proliferation of LS1034 in monolayer culture and additively augmented the number of colonies formed in methylcellulose. Furthermore, TGF beta 1 strongly reduced the growth rate of LS1034. Low amounts of TGF beta 1 markedly inhibited the response of LS1034 to IL-1 and totally abrogated proliferation induced by IL-6. We conclude that different cytokines can provide distinct signals for the regulation of growth of colorectal carcinoma cells.
Archive | 1992
Emilia Saraga; N. de Quay; Jean-Claude Givel; Xavier Albe
In an attempt to improve the prognostic accuracy for colon carcinoma, numerous alternative classifications have been proposed [1–13].
International Journal of Cancer | 1994
Harald Lahm; Paul Amstad; Josiane Wyniger; Aysim Yilmaz; Jürgen Fischer; Magali Schreyer; Jean-Claude Givel
Cancer | 1990
Xavier Albe; Pierre Vassilakos; Karine Helfer-Guarnori; Jean-Claude Givel; Nicolas de Quay; Laurent Suardet; James F. Eliason; Nicolas Odartchenko
Cancer Research | 1992
Suardet L; Gaide Ac; Calmès Jm; Sordat B; Jean-Claude Givel; Eliason Jf; Nicolas Odartchenko
European Journal of Cancer | 1992
H.T. Tevaearai; Jean-Claude Givel; P.L. Laurent; L. Suardet; James F. Eliason; Nicolas Odartchenko
Cancer Research | 1994
Harald Lahm; Josiane Wyniger; Sylvie Hertig; Aysim Yilmaz; Jürgen Fischer; Jean-Claude Givel; Nicolas Odartchenko
International Journal of Cancer | 1994
Harald Lahm; Bruno Schnyder; Josiane Wyniger; Zita Borbenyi; Aysim Yilmaz; Bruce D. Car; Jürgen Fischer; Jean-Claude Givel; Bernhard Ryffel
Biochemical and Biophysical Research Communications | 1996
Harald Lahm; Paul Amstad; Aysim Yilmaz; Jürgen Fischer; Jean-Claude Givel; Nicolas Odartchenko; Bernard Sordat